Send the link below via email or IMCopy
Present to your audienceStart remote presentation
- Invited audience members will follow you as you navigate and present
- People invited to a presentation do not need a Prezi account
- This link expires 10 minutes after you close the presentation
- A maximum of 30 users can follow your presentation
- Learn more about this feature in our knowledge base article
Integumentary System Disease Project
Transcript of Integumentary System Disease Project
Continue your treatment plan. Once rosacea improves or clears, you need to continue your maintenance treatment plan as outlined by your doctor. This may mean daily use of topical medications or continuing lifestyle or self-care measures.
Be gentle to your skin. Wash areas daily with a gentle cleanser and use oil-free, water-based skin care products. Avoid using products that contain skin irritants, such as alcohol.
Avoid rosacea triggers, if possible. Find out what triggers, if any, worsen your rosacea and take steps to prevent or avoid them. Extreme temperatures, sun exposure, spicy foods, alcohol and stress can all trigger rosacea. Treatment Though there's no way to eliminate rosacea, effective treatment can relieve signs and symptoms. Most often this requires a combination of prescription treatments and certain lifestyle changes on your part.
Topical Medications: Medications you apply to your skin once or twice daily may help reduce inflammation and redness. Common topical medications include antibiotics such as Metrocream, Metrogel, Atralin, Renova, and benzoyl peroxide. These topical applications can cause skin irritation, redness, dry skin, and stinging or burning of the skin.
Surgery: Some redness and changes often become permanent. In these cases, surgical methods, such as laser surgery and electrosurgery, may reduce the visibility of blood vessels, remove tissue buildup around your nose and generally improve your appearance. Epidemiology The epidemiological data on Rosacea remain fragmentary. Rosacea affects mainly adults around the age of 30 years and classically predominates in females. Recent Estonian and Irish studies suggest that the female predominance may not be as high as previously believed. However, prevalence does increase with age. The prevalence statistics published in Europe and the United States are highly variable, ranging from less than 1% to more than 20% of the adult population; actually, the methods used and the populations studied vary greatly from one study to another; consequently, they cannot be compared.